• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Structure-guided design, synthesis, and characterization of next-generation meprin v inhibitors
 
  • Details
  • Full
Options
2018
Journal Article
Title

Structure-guided design, synthesis, and characterization of next-generation meprin v inhibitors

Abstract
The metalloproteinase meprin v emerged as a current drug target for the treatment of a number of disorders, among those fibrosis, inflammatory bowel disease and Morbus Alzheimer. A major obstacle in the development of metalloprotease inhibitors is target selectivity to avoid side effects by blocking related enzymes with physiological functions. Here, we describe the structure-guided design of a novel series of compounds, based on previously reported highly active meprin v inhibitors. The bioisosteric replacement of the sulfonamide scaffold gave rise to a next generation of meprin inhibitors. Selected compounds based on this novel amine scaffold exhibit high activity against meprin v and also remarkable selectivity over related metalloproteases, i.e., matrix metalloproteases and A disintegrin and metalloproteinases.
Author(s)
Ramsbeck, Daniel
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Hamann, Antje
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Richter, Georg
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Schlenzig, Dagmar
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Geißler, Stefanie
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Nykiel, Vera
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Cynis, Holger
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Schilling, Stephan
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Buchholz, Mirko
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Journal
Journal of medicinal chemistry  
Open Access
DOI
10.1021/acs.jmedchem.8b00330
Additional full text version
Landing Page
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024